Patents by Inventor Peter Gordon Parsons
Peter Gordon Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220193023Abstract: The present invention relates to methods of treating tumours comprising the localised administration, for example, intratumourally or topically, of an epoxytiglienone compound (as a monotherapy) to cancerous tumours to generate a systemic anticancer C abscopal (anenestic) and/or bystander effect.Type: ApplicationFiled: April 9, 2020Publication date: June 23, 2022Applicant: QBIOTICS PTY LTDInventors: Victoria Anne GORDON, Paul Warren REDDELL, Glen Mathew BOYLE, Jason Kingsley CULLEN, Peter Gordon PARSONS
-
Patent number: 11213506Abstract: The present invention relates to a combination therapy for tumours comprising the administration of an epoxytigliane compound and an immune checkpoint inhibitor. In particular embodiments, there is a method of treating a tumour and/or treating or preventing one or more bystander tumours with the therapy. Pharmaceutical compositions and kits containing epoxytigliane compounds and immune checkpoint inhibitors are also described.Type: GrantFiled: March 23, 2018Date of Patent: January 4, 2022Assignee: QBIOTICS PTY LTDInventors: Paul Warren Reddell, Jason Kingsley Cullen, Glen Mathew Boyle, Peter Gordon Parsons, Victoria Anne Gordon
-
Patent number: 10822317Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.Type: GrantFiled: November 21, 2018Date of Patent: November 3, 2020Assignee: QBIOTICS PTY LTDInventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
-
Publication number: 20200030279Abstract: The present invention relates to a combination therapy for tumours comprising the administration of an epoxytigliane compound and an immune checkpoint inhibitor. In particular embodiments, there is a method of treating a tumour and/or treating or preventing one or more bystander tumours with the therapy. Pharmaceutical compositions and kits containing epoxytigliane compounds and immune checkpoint inhibitors are also described.Type: ApplicationFiled: March 23, 2018Publication date: January 30, 2020Inventors: Paul Warren Reddell, Jason Kingsley Cullen, Glen Mathew Boyle, Peter Gordon Parsons, Victoria Anne Gordon
-
Publication number: 20190161462Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds Sand compositions for use in wound healing are also described.Type: ApplicationFiled: November 21, 2018Publication date: May 30, 2019Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
-
Publication number: 20190160035Abstract: The present invention relates to methods of treating mast cell tumors and soft tissue sarcomas using 6,7-epoxy-4,5,9,12,13,20-hexahydroxy-1-tigliaen-3-one derivatives in combination with at least one other pharmaceutically active agent. In particular embodiments, the tigliaen-3-one derivatives are 12, 13-acyl or ether derivatives and the derivative compound is delivered in a localised manner to the tumor or sarcoma. In particular embodiments, the at least one other pharmaceutically active agent is selected from an antihistamine, an anti-inflammatory agent and mixtures thereof.Type: ApplicationFiled: July 28, 2017Publication date: May 30, 2019Inventors: Peter Gordon PARSONS, Peter Frederick SCHMIDT, Charles Stewart LOWDEN, Justine Emma CAMPBELL, Victoria GORDON
-
Patent number: 10183922Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.Type: GrantFiled: February 6, 2017Date of Patent: January 22, 2019Assignee: QBiotics LimitedInventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
-
Patent number: 10183921Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.Type: GrantFiled: April 17, 2014Date of Patent: January 22, 2019Assignee: QBiotics LimitedInventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
-
Publication number: 20170144981Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.Type: ApplicationFiled: February 6, 2017Publication date: May 25, 2017Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
-
Patent number: 9314458Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogs or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species.Type: GrantFiled: February 24, 2011Date of Patent: April 19, 2016Assignee: LEO Laboratories LimitedInventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Publication number: 20160068499Abstract: The present invention relates to epoxy-tigliane compounds and their use in promoting wound healing. In particular embodiments, the epoxy-tigliane compounds are epoxy-tigliaen-3-one compounds. Methods of inducing or promoting wound healing as well as methods of reducing scarring and improving cosmetic outcomes upon healing of a wound are described. Compounds and compositions for use in wound healing are also described.Type: ApplicationFiled: April 17, 2014Publication date: March 10, 2016Inventors: Paul Warren Reddell, Victoria Anne Gordon, Ryan Moseley, Robert Steadman, Rachael Louise Moses, Glen Mathew Boyle, Peter Gordon Parsons
-
Publication number: 20110213002Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species.Type: ApplicationFiled: February 24, 2011Publication date: September 1, 2011Applicant: Peplin Research Pty Ltd.Inventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Patent number: 7838555Abstract: The present invention relates to the treatment of acne vulgaris in a subject by administering to the subject an ingenane of the formula wherein R24-R26 are herein defined.Type: GrantFiled: December 9, 2002Date of Patent: November 23, 2010Assignee: Peplin Research Pty LtdInventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Publication number: 20100048698Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species.Type: ApplicationFiled: August 18, 2009Publication date: February 25, 2010Applicant: PEPLIN RESEARCH PTY LTD.Inventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Patent number: 7449492Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of infection by pathogenic or potentially pathogenic entities, or entities capable of opportunistic infection in mammals, including humans and primates, non-mammalian animals and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of infection by pathogenic entities in mammalian, animal and avian subjects.Type: GrantFiled: December 9, 2002Date of Patent: November 11, 2008Assignee: Peplin Research Pty, Ltd.Inventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Patent number: 7378445Abstract: A chemical agent of the diterpene family obtained from a member of the Euphorbiaceae family of plants for use in the treatment of prophylaxis of prostate cancer or a related cancer or condition.Type: GrantFiled: January 3, 2006Date of Patent: May 27, 2008Assignee: Peplin Research Pty. Ltd.Inventors: James Harrison Aylward, Peter Gordon Parsons
-
Publication number: 20030195168Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of protein kinase C (PKC) related conditions in mammals, including humans and primates, non-mammalian animals and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chermical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of PKC-related conditions in mammalian, animal and avian subjects. The subject chemical agents are also useful for modulating expression of genetic sequences including promotion and other regulatory sequences.Type: ApplicationFiled: December 9, 2002Publication date: October 16, 2003Inventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Publication number: 20030171334Abstract: A chemical agent of the diterpene family obtained from a member of the Euphorbiaceae family of plants for use in the treatment of prophylaxis of prostate cancer or a related cancer or condition.Type: ApplicationFiled: February 24, 2003Publication date: September 11, 2003Inventors: James Harrison Aylward, Peter Gordon Parsons
-
Publication number: 20030171337Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtaining from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of an inflammatory condition or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammal, animal or avian species.Type: ApplicationFiled: December 9, 2002Publication date: September 11, 2003Inventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner
-
Publication number: 20030166613Abstract: The present invention relates generally to chemical agents useful in the treatment and prophylaxis of infection by pathogenic or potentially pathogenic entities, or entities capable of opportunistic infection in mammals, including humans and primates, non-mammalian animals and avian species. More particularly, the present invention provides a chemical agent of the macrocyclic diterpene family obtainable from a member of the Euphorbiaceae family of plants or botanical or horticultural relatives thereof or derivatives or chemical analogues or chemically synthetic forms of the agents for use in the treatment or prophylaxis of infection by pathogenic entities in mammalian, animal and avian subjects.Type: ApplicationFiled: December 9, 2002Publication date: September 4, 2003Inventors: James Harrison Aylward, Peter Gordon Parsons, Andreas Suhrbier, Kathleen Anne Turner